By Editor , 15 October 2026
Benchling Launches Science Foundries for End-to-End Agentic R&D

San Francisco – October 15, 2026 -- Benchling launched Science Foundries, a product that lets R&D teams run entire scientific processes with agents and scientists working from the same data, and made it available to its customers the same day.

Teams select a process or goal, such as producing proteins, optimizing a lead or improving a manufacturing process. They then define which steps agents run and where scientists must approve. Agents execute and monitor work, coordinate handoffs and flag key decisions to scientists.

By Editor , 28 September 2026
Sixty Degree Capital Portfolio Delivers Record SpaceX, Biotech IPOs in 2026

Toronto – September 28, 2026 -- Sixty Degree Capital (SDC) saw five portfolio companies complete initial public offerings in 2026, including the largest IPO in history and the largest biotech IPO on record. SpaceX, Parabilis Medicines, Cerebras, HawkEye 360 and Lime each began trading on U.S. exchanges between May and July, while GrubMarket has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission.